Category: Weightloss
-
Roche falls while Novo, Lilly gain on weight-loss drug report (OTCQX:RHHBY)
•
HJBC Roche (OTCQX: RHHBY) shares fell 5% on Wednesday while shares of rivals Novo Nordisk (NVO) and Eli Lilly (NYSE:LLY) gained ground after Reuters reported that positive data from Roche (OTCQX:RHHBY) in July The obesity drug candidate CT-996 was based on just six study participants. In July, Roche said a…
-
US FDA flags dosing risks from compounded versions of Novo’s weight-loss drug By Reuters
•
(Reuters) – The U.S. Food and Drug Administration on Friday warned patients and doctors about dosing errors linked to combination versions of Novo Nordisk’s weight-loss and diabetes drugs. The health regulator said it had received reports of adverse events, some requiring hospitalization, that may have been linked to overdoses caused…